Three Suspects Remanded in FIA Custody Over Counterfeit Vaccine Case
ISLAMABAD: A judicial magistrate has granted the Federal Investigation Agency (FIA) a five-day physical remand of three suspects, including the CEO of a private laboratory, in connection with the alleged administration of counterfeit and substandard flu vaccines to patients.
Judicial Magistrate Shaista Kundi approved the remand after the FIA presented the marketing manager and an assistant manager of the lab in court. The agency had initially requested a 14-day remand to thoroughly investigate the alleged supply and administration of these counterfeit vaccines, but the court limited it to five days.
The FIA’s Anti-Corruption Circle in Islamabad arrested the suspects following a joint operation with a drug inspector at a laboratory located in the capital’s Blue Area. During this operation, authorities reportedly seized 27 injections of counterfeit flu vaccine, specifically the Influvac Tetra vaccine, which bore lot number P13. The FIA informed the court that these substandard doses had been administered to patients, raising serious health concerns.
This case highlights the ongoing issues surrounding vaccine safety and public health in Pakistan, as counterfeit medical products pose significant risks to patients. The FIA’s investigation is expected to delve deeper into the operations of the laboratory and the broader implications for healthcare regulations in the country.